The Accumulation of Gut Microbiome-derived Indoxyl Sulfate and P-Cresyl Sulfate in Patients With End-stage Renal Disease

被引:22
作者
Lin, Xuechun [1 ,2 ]
Liang, Wangqun [3 ]
Li, Li [2 ]
Xiong, Qianqian [2 ]
He, Shuiqing [2 ]
Zhao, Jing [2 ]
Guo, Xiaolei [2 ]
Xiang, Siyun [4 ]
Zhang, Piwei [1 ]
Wang, Hong [5 ]
Ying, Chenjiang [2 ]
Yao, Ying [1 ,3 ]
Zuo, Xuezhi [1 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Clin Nutr, Wuhan 430030, Hubei, Peoples R China
[2] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Nutr & Food Hyg,Hubei Key Lab Food Nutr & Sa, Wuhan, Hubei, Peoples R China
[3] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Div Nephrol, Wuhan 430030, Hubei, Peoples R China
[4] Henan Prov Peoples Hosp, Dept Nutr, Zhengzhou, Peoples R China
[5] Wuhan Inst Food & Cosmet Control, Wuhan, Hubei, Peoples R China
基金
中国国家自然科学基金;
关键词
end-stage renal disease; indoxyl sulfate; p-cresyl sulfate; gut microbiome; CHRONIC KIDNEY-DISEASE; UREMIC TOXINS; CKD; INDOLE;
D O I
10.1053/j.jrn.2021.09.007
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Objectives: Indoxyl sulfate (IS) and p-cresyl sulfate (pCS) are two important gut microbiota-generated protein-bound uremic toxins. The present study aims to explore the alterations of serum IS and pCS concentrations, their production, and daily removal in end-stage renal disease (ESRD). Methods: A case-controlled study was conducted based on 11 patients with ESRD and 11 healthy volunteers. The metabolic processes for IS and pCS were compared in these two groups, including gut microbiome, fecal indole and p-cresol, indole-producing bacteria and p-cresol-producing bacteria, serum total IS and pCS concentrations, and their daily removal by urine and spent dialyzate. Results: Compared with healthy controls, patients with ESRD exhibited higher relative abundance of the indole-producing bacteria Escherichia coli (P < .001) and Bacteroides fragilis (P = .010) and p-cresol-producing bacteria Bacteroides fragilis (P = .010) and Bacteroides caccae (P = .047). The predicted functional profiles of gut microbiome based on 16S rRNA gene PhyloChip analysis showed that the microbial tryptophan metabolism pathway (map00380, P = .0006) was significantly enriched in patients with ESRD. However, the fecal precursors indole (P = .332) and p-cresol concentrations (P = .699) were comparable between the two groups. The serum IS (P < .001) and pCS (P < .001) concentrations were far higher in patients with ESRD than those in healthy controls, whereas the daily total removal by urine and dialyzate was much lower for the former than that for the latter (P = .019 for IS, P = .016 for pCS). Conclusions: The present study showed serious IS and pCS accumulation in patients with ESRD, with significant expansion of indoleproducing bacteria and p-cresol-producing bacteria, upregulation of the bacterial tryptophan metabolism pathway, and greatly increased serum IS and pCS concentrations, whereas significant decline of daily IS and pCS removal.
引用
收藏
页码:578 / 586
页数:9
相关论文
共 30 条
[1]   Gut microbiome and kidney disease: a bidirectional relationship [J].
Al Khodor, Souhaila ;
Shatat, Ibrahim F. .
PEDIATRIC NEPHROLOGY, 2017, 32 (06) :921-931
[2]   Impairment of small intestinal protein assimilation in patients with end-stage renal disease: extending the malnutrition-inflammationatherosclerosis concept [J].
Bammens, B ;
Evenepoel, P ;
Verbeke, K ;
Vanrenterghem, Y .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2004, 80 (06) :1536-1543
[3]   Major role of organic anion transporter 3 in the transport of indoxyl sulfate in the kidney [J].
Deguchi, T ;
Ohtsuki, S ;
Otagiri, M ;
Takanaga, H ;
Asaba, H ;
Mori, S ;
Terasaki, T .
KIDNEY INTERNATIONAL, 2002, 61 (05) :1760-1768
[4]   Exploring Protein Binding of Uremic Toxins in Patients with Different Stages of Chronic Kidney Disease and during Hemodialysis [J].
Deltombe, Olivier ;
Van Biesen, Wim ;
Glorieux, Griet ;
Massy, Ziad ;
Dhondt, Annemieke ;
Eloot, Sunny .
TOXINS, 2015, 7 (10) :3933-3946
[5]   Normal and Pathologic Concentrations of Uremic Toxins [J].
Duranton, Flore ;
Cohen, Gerald ;
De Smet, Rita ;
Rodriguez, Mariano ;
Jankowski, Joachim ;
Vanholder, Raymond ;
Argiles, Angel .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 23 (07) :1258-1270
[6]   Uremic toxins originating from colonic microbial metabolism [J].
Evenepoel, Pieter ;
Meijers, Bjorn K. I. ;
Bammens, Bert R. M. ;
Verbeke, Kristin .
KIDNEY INTERNATIONAL, 2009, 76 :S12-S19
[7]   Role of Uremic Toxins for Kidney, Cardiovascular, and Bone Dysfunction [J].
Fujii, Hideki ;
Goto, Shunsuke ;
Fukagawa, Masafumi .
TOXINS, 2018, 10 (05)
[8]   Low dietary fiber intake increases Collinsella abundance in the gut microbiota of overweight and obese pregnant women [J].
Gomez-Arango, Luisa F. ;
Barrett, Helen L. ;
Wilkinson, Shelley A. ;
Callaway, Leonie K. ;
Mcintyre, H. David ;
Morrison, Mark ;
Nitert, Marloes Dekker .
GUT MICROBES, 2018, 9 (03) :189-201
[9]   On the operational characteristics of the Benjamini and Hochberg false discovery rate procedure [J].
Green, Gerwyn H. ;
Diggle, Peter J. .
STATISTICAL APPLICATIONS IN GENETICS AND MOLECULAR BIOLOGY, 2007, 6
[10]   Gut microbiota generation of protein -bound uremic toxins and related metabolites is not altered at different stages of chronic kidney disease see [J].
Gryp, Tessa ;
De Paepe, Kim ;
Vanholder, Raymond ;
Kerckhof, Frederiek-Maarten ;
Van Biesen, Wim ;
Van de Wiele, Tom ;
Verbeke, Francis ;
Speeckaert, Marijn ;
Joossens, Marie ;
Couttenye, Marie Madeleine ;
Vaneechoutte, Mario ;
Glorieux, Griet .
KIDNEY INTERNATIONAL, 2020, 97 (06) :1230-1242